» Authors » Isida Byku

Isida Byku

Explore the profile of Isida Byku including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 118
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Modi R, Ueyama H, Tully A, Byku I, Greenbaum A, Xie J, et al.
Innovations (Phila) . 2025 Jan; 20(1):39-47. PMID: 39851206
Objective: Percutaneous vegetation debulking has been reported to treat tricuspid valve infective endocarditis (TVIE), but data on feasibility compared with conventional surgical strategies are limited. We aimed to compare short-term...
2.
Perdoncin E, Paone G, Byku I
US Cardiol . 2024 Nov; 16:e09. PMID: 39600835
While redo surgical aortic valve replacement has traditionally been the gold standard for the treatment of failed surgical valves, valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) has arisen as a...
3.
Ueyama H, Lederman R, Inci E, Lisko J, Xie J, Byku I, et al.
Circ Cardiovasc Interv . 2024 Oct; 17(11):e014440. PMID: 39445420
No abstract available.
4.
Tchetche D, Mehran R, Blackman D, Khalil R, Mollmann H, Abdel-Wahab M, et al.
JAMA Cardiol . 2024 Oct; 9(12):1106-1114. PMID: 39382856
Importance: Historically, women with aortic stenosis have experienced worse outcomes and inadequate recognition compared to men, being both underdiagnosed and undertreated, while also facing underrepresentation in clinical trials. Objective: To...
5.
Lisko J, Shekiladze N, Chamoun J, Sheikh N, Rainer K, Wei J, et al.
J Soc Cardiovasc Angiogr Interv . 2024 Aug; 3(1):101184. PMID: 39131978
Background: Radiation exposure during invasive cardiovascular procedures remains an important health care issue. Lead aprons and shields (LAS) are used to decrease radiation exposure but leave large portions of the...
6.
Mekary W, Hebbo E, Shah A, Westerman S, Bhatia N, Byku I, et al.
Heart Rhythm . 2024 Jul; 22(2):311-317. PMID: 38969051
Background: Data on transvenous (TV) lead-associated superior vena cava (SVC) syndrome are limited. The management of this problem might require a multidisciplinary approach, often involving transvenous lead extraction (TLE) followed...
7.
Ueyama H, Licitra G, Gleason P, Behbahani-Nejad O, Modi R, Rajagopal D, et al.
Am J Cardiol . 2024 Apr; 220:84-91. PMID: 38604492
Development of functional tricuspid regurgitation (TR) because of chronic mitral disease and subsequent heart failure is common. However, the effect of TR on clinical outcomes after transcatheter mitral valve replacement...
8.
Greenbaum A, Ueyama H, Gleason P, Khan J, Bruce C, Halaby R, et al.
J Am Coll Cardiol . 2024 Mar; 83(14):1257-1272. PMID: 38471643
Background: Left ventricular outflow tract (LVOT) obstruction is a source of morbidity in hypertrophic cardiomyopathy (HCM) and a life-threatening complication of transcatheter mitral valve replacement (TMVR) and transcatheter aortic valve...
9.
Ueyama H, Greenbaum A, Xie J, Shekiladze N, Gleason P, Byku I, et al.
JACC Cardiovasc Interv . 2024 Jan; 17(5):635-644. PMID: 38244000
Background: Transcatheter closure of transcatheter heart valve (THV)-related paravalvular leak (PVL) is associated with a high failure rate with available devices due to the complex interaction of THV and aortic/mitral...
10.
Ueyama H, Xie J, Hanzel G, Byku I, Paone G, Grubb K, et al.
Circ Cardiovasc Interv . 2023 Dec; 17(1):e013325. PMID: 38047373
No abstract available.